Financial results - DIAGNOSTIC DOCTOR OPREA SRL

Financial Summary - Diagnostic Doctor Oprea Srl
Unique identification code: 16885340
Registration number: J27/1484/2004
Nace: 8622
Sales - Ron
21.874
Net Profit - Ron
2.601
Employee
1
The most important financial indicators for the company Diagnostic Doctor Oprea Srl - Unique Identification Number 16885340: sales in 2023 was 21.874 euro, registering a net profit of 2.601 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Diagnostic Doctor Oprea Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 26.730 35.086 25.713 24.501 28.771 33.910 19.723 22.682 23.146 21.874
Total Income - EUR 26.795 35.164 25.736 24.523 28.771 33.910 19.723 22.682 24.160 26.928
Total Expenses - EUR 21.887 32.148 23.296 17.025 25.748 31.492 15.742 19.674 21.278 24.056
Gross Profit/Loss - EUR 4.909 3.016 2.439 7.498 3.023 2.418 3.980 3.008 2.882 2.872
Net Profit/Loss - EUR 4.106 1.964 1.850 2.659 2.735 2.079 3.845 2.896 2.620 2.601
Employees 2 1 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -5.2%, from 23.146 euro in the year 2022, to 21.874 euro in 2023. The Net Profit decreased by -11 euro, from 2.620 euro in 2022, to 2.601 in the last year.

Check the financial reports for the company - Diagnostic Doctor Oprea Srl

Rating financiar

Financial Rating -
Diagnostic Doctor Oprea Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Diagnostic Doctor Oprea Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Diagnostic Doctor Oprea Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Diagnostic Doctor Oprea Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Diagnostic Doctor Oprea Srl - CUI 16885340

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 81.366 82.435 77.056 69.692 59.650 44.192 38.144 30.183 23.157 18.801
Current Assets 3.893 1.323 1.479 1.306 1.150 633 441 324 421 2.465
Inventories 0 433 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0
Cash 3.893 890 1.479 1.306 1.150 633 441 324 421 2.465
Shareholders Funds 12.585 14.654 1.894 2.703 2.778 2.121 3.886 2.936 2.661 2.642
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 72.674 69.104 76.641 68.294 58.023 42.704 34.700 27.571 20.917 18.624
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.465 euro in 2023 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 2.465 euro.
The company's Equity was valued at 2.642 euro, while total Liabilities amounted to 18.624 euro. Equity decreased by -11 euro, from 2.661 euro in 2022, to 2.642 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Diagnostic Doctor Oprea Srl

Comments - Diagnostic Doctor Oprea Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.